Recent MREO News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 06/11/2025 11:51:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2025 08:30:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:57:24 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:48:47 AM
- Mereo BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Highlights • GlobeNewswire Inc. • 05/13/2025 11:30:05 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/08/2025 10:41:16 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/04/2025 04:39:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2025 11:38:40 AM
- Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights • GlobeNewswire Inc. • 03/26/2025 11:30:36 AM
- Mereo BioPharma to Participate in Fireside Chat at the Leerink Partners Global Healthcare Conference • GlobeNewswire Inc. • 03/05/2025 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 09:30:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 09:30:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2025 09:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/28/2025 09:05:07 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/23/2025 09:07:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/13/2025 11:32:39 AM
- Mereo BioPharma Provides Update on Lead Clinical Programs • GlobeNewswire Inc. • 01/12/2025 04:05:16 PM
- Mereo BioPharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/07/2025 12:30:12 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/04/2024 09:52:12 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/25/2024 09:16:08 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 08:30:42 PM
VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM
ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM
Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM
NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM
Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM
Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM